Frequency Therapeutics Overview

  • Founded
  • 2015
Founded
  • Status
  • Public
  • Employees
  • 87
Employees
  • Stock Symbol
  • FREQ
Stock Symbol
  • Share Price
  • $7.86
  • (As of Tuesday Closing)

Frequency Therapeutics General Information

Description

Frequency Therapeutics Inc is a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by degenerative diseases. Its Progenitor Cell Activation approach uses combinations of molecules to activate progenitor cells within the body to create functional tissue. Its product candidate FX-322 is being developed for treating sensorineural hearing loss.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 19 Presidential Way
  • Woburn, MA 01801
  • United States
+1 (781) 000-0000

Frequency Therapeutics Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Frequency Therapeutics Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$7.86 $7.76 $7.34 - $58.37 $266M 34.2M 503K -$1.25

Frequency Therapeutics Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 150,342 967,495 526,014
Revenue 34,371 36,984 28,947 0
EBITDA (41,522) (26,324) (19,717) (18,408)
Net Income (41,973) (26,511) (18,746) (19,168)
Total Assets 241,511 264,722 223,218 44,548
Total Debt 46,482 45,994 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Frequency Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Frequency Therapeutics‘s full profile, request access.

Request a free trial

Frequency Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Frequency Therapeutics‘s full profile, request access.

Request a free trial

Frequency Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Frequency Therapeutics Inc is a clinical-stage biotechnology company focused on harnessing the body's innate biology to
Drug Discovery
Woburn, MA
87 As of 2020
00000
000000000 00000

000000 0

uip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum d
0000 000000000
Lexington, MA
00 As of 0000
00000
0000 0000-00-00
00000000 00000

00000000

liqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea comm
0000000000000
Gaithersburg, MD
00 As of 0000
00000
0000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Frequency Therapeutics Competitors (17)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cyteir Therapeutics Venture Capital-Backed Lexington, MA 00 00000 00000000 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
0000000 0000000000 Formerly VC-backed Boston, MA 00 00000 00000000 00000
0000000 Venture Capital-Backed Oslo, Norway 00 0000000000
0000000 0000000000 Venture Capital-Backed Tübingen, Germany 000.00 00000000000 000.00
You’re viewing 5 of 17 competitors. Get the full list »

Frequency Therapeutics Executive Team (12)

Name Title Board Seat Contact Info
David Lucchino Board Member, President, Chief Executive Officer & Co-Founder
Peter Pfreundschuh Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Christopher Loose Ph.D Chief Scientific Officer & Co-Founder
Carl LeBel Ph.D Chief Development Officer
Quentin McCubbin Ph.D Chief Manufacturing Officer
You’re viewing 5 of 12 executive team members. Get the full list »

Frequency Therapeutics Board Members (11)

Name Representing Role Since
Cynthia Feldmann Frequency Therapeutics Board Member 000 0000
Daguang Wang Ph.D Yongjin Group Board Observer 000 0000
Frederick Shane DNU_Axil Capital Partners Board Observer 000 0000
Joel Marcus JD Self Board Member 000 0000
Marc Cohen Self Chairman & Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Frequency Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial